Stanley Druckenmiller's position in Verona Pharma Plc is currently worth $105 Million. That's 3.01% of their equity portfolio (10th largest holding). The investor owns 1.18% of the outstanding Verona Pharma Plc stock. The stake costed the investor $31.3 Million, netting the investor a gain of 236% so far.